RESEARCH-USE BIOSIMILAR ANTIBODY
Cifurtilimab
Monoclonal antibody · IgG1
Cifurtilimab (SEA-CD40) is an agonistic nonfucosylated, human IgG1 monoclonal antibody directed against CD40. Cifurtilimab shows antitumor activities.
TARGETTNFRSF5
YMonoclonal antibody
CATALOGSC-BS-669
CATALOG NUMBERSC-BS-669
MOLECULAR WEIGHTApprox. 145.1 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Cifurtilimab (SEA-CD40) is an agonistic nonfucosylated, human IgG1 monoclonal antibody directed against CD40. Cifurtilimab shows antitumor activities.
Cifurtilimab is a recombinant research-use antibody directed against TNFRSF5.